UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

The Journal of biological chemistry, 2005-01, Vol.280 (1), p.556-563

2005

Link zum Volltext

Verfügbarkeit prüfen

Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models

Annals of the New York Academy of Sciences, 2008-12, Vol.1147 (1), p.358-382

Browne, Susan E

2008

Link zum Volltext

Verfügbarkeit prüfen

pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation

The FASEB journal, 2007-01, Vol.21 (1), p.179-187

2007

Link zum Volltext

Verfügbarkeit prüfen

Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS

Neurobiology of disease, 2006-06, Vol.22 (3), p.599-610

2006

Link zum Volltext

Verfügbarkeit prüfen

Oxidative damage in Huntington's disease pathogenesis

Antioxidants & redox signaling, 2006-11, Vol.8 (11-12), p.2061

2006

Link zum Volltext

Verfügbarkeit prüfen

Mitochondria and Huntington's Disease Pathogenesis

Annals of the New York Academy of Sciences, 2008-12, Vol.1147 (1), p.358-382

Browne, Susan E.

2008

Link zum Volltext

Verfügbarkeit prüfen

Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease

Neurobiology of disease, 2001-06, Vol.8 (3), p.479-491

2001

Link zum Volltext

Verfügbarkeit prüfen

Minocycline enhances MPTP toxicity to dopaminergic neurons

Journal of neuroscience research, 2003-10, Vol.74 (2), p.278-285

2003

Link zum Volltext

Verfügbarkeit prüfen

When too much ATP is a bad thing: a pivotal role for P2X7 receptors in motor neuron degeneration

Journal of neurochemistry, 2013-08, Vol.126 (3), p.301-304

Browne, Susan E.

2013

Link zum Volltext

Verfügbarkeit prüfen

Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators

Frontiers in neuroscience, 2013-01, Vol.7, p.254-254

2013

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species

The Journal of neuroscience, 2004-09, Vol.24 (36), p.7779-7788

2004

Link zum Volltext

Verfügbarkeit prüfen

Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression

Neurobiology of disease, 2002-12, Vol.11 (3), p.410-424

2002

Link zum Volltext

Verfügbarkeit prüfen

A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease

The Journal of pharmacology and experimental therapeutics, 2012-10, Vol.343 (1), p.167

2012

Link zum Volltext

Verfügbarkeit prüfen

Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders

The Journal of pharmacology and experimental therapeutics, 2014-09, Vol.350 (3), p.495

2014

Link zum Volltext

Verfügbarkeit prüfen

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

Human molecular genetics, 2004-04, Vol.13 (7), p.703-714

2004

Link zum Volltext

Verfügbarkeit prüfen

The energetics of Huntington's disease

Neurochemical research, 2004-03, Vol.29 (3), p.531-546

2004

Link zum Volltext

Verfügbarkeit prüfen

Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease

Neurobiology of disease, 2006-12, Vol.24 (3), p.455-465

2006

Link zum Volltext

Verfügbarkeit prüfen

Oxidative Stress in Huntington's Disease

Brain pathology (Zurich, Switzerland), 1999-01, Vol.9 (1), p.147-163

1999

Link zum Volltext

Verfügbarkeit prüfen

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Annals of neurology, 1997-05, Vol.41 (5), p.646-653

1997

Link zum Volltext

Verfügbarkeit prüfen

Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis

Annals of neurology, 1997-10, Vol.42 (4), p.644-654

1997

Link zum Volltext

Verfügbarkeit prüfen

Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis

Journal of neurochemistry, 1997-11, Vol.69 (5), p.2064-2074

1997

Link zum Volltext

Verfügbarkeit prüfen

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

European journal of pharmacology, 2014-04, Vol.728, p.31-38

2014

Link zum Volltext

Verfügbarkeit prüfen

Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3‐nitropropionic acid neurotoxicity

Journal of neurochemistry, 2004-03, Vol.88 (6), p.1352-1360

2004

Link zum Volltext

Verfügbarkeit prüfen

Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex

Neuroscience letters, 1999-09, Vol.272 (1), p.53-56

1999

Link zum Volltext

Verfügbarkeit prüfen

Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia–telangiectasia mice

Free radical biology & medicine, 2004-04, Vol.36 (7), p.938-942

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(137)

Publikationsform

Sprache

Englisch
(161)
Japanisch
(29)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models

pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation

Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS

Oxidative damage in Huntington's disease pathogenesis

Mitochondria and Huntington's Disease Pathogenesis

Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease

Minocycline enhances MPTP toxicity to dopaminergic neurons

When too much ATP is a bad thing: a pivotal role for P2X7 receptors in motor neuron degeneration

Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators

Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species

Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene Expression

A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease

Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders

CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation

The energetics of Huntington's disease

Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease

Oxidative Stress in Huntington's Disease

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis

Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis

Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice

Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3‐nitropropionic acid neurotoxicity

Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex

Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia–telangiectasia mice

Suchergebnisse filtern